You are here

Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain. Part 2 Management

Daniel Bennett, MD, Allen W. Burton, MD, Scott Fishman, MD, Barry Fortner, PhD, Bill McCarberg, MD, Chris Miaskowski, PhD, RN, David Nash, MD, MBA, Marco Pappagallo, MD, Richard Payne, MD, James Ray, PharmD, Eugene R. Viscusi, MD, and Winston Wong, PharmD
PDF version: 
The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.